BIOPALETTE
LIVE

Serial Number

98463652

Owner

Bio Palette Co., Ltd.

Attorney

Subaru Ryan Kanesaka

Filing Date

Mar 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BIOPALETTE Trademark

Serial Number: 98463652 • Registration: 7831426

BIOPALETTE is a trademark filed by Bio Palette Co., Ltd. on March 22, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

Bio Palette Co., Ltd. (6 trademarks)

6-1, Otemachi 1-chome
Chiyoda-ku 100-0004 , JP

Entity Type: 03

Trademark Details

Filing Date

March 22, 2024

Registration Date

June 17, 2025

Published for Opposition

April 29, 2025

Goods & Services

Pharmaceutical preparations for medical purposes produced by genome or gene editing operation for treatment, diagnosis and prevention of human diseases and conditions, namely, for treatment, diagnosis and prevention of inflammatory diseases, cancer, neurodegenerative diseases, lifestyle diseases, autoimmune diseases, infectious diseases, digestive diseases and endocrine-metabolic diseases; chemical reagents for medical purposes produced by genome or gene editing operation; cultures of microorganisms for medical or veterinary use produced by genome or gene editing operation; living cells, cultures of microorganisms, proteins being protein arrays for medical and veterinary diagnosis purposes, peptides being diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates, nucleic acid, and combinations thereof, all the aforementioned for medical or veterinary purposes produced by genome or gene editing operation; biological preparations for use in cell cultures for medical purposes, namely, biological cells for surgical implantation produced by genome or gene editing operation; pharmaceutical preparations, biological preparations for use in cell cultures, and diagnostic products in the nature of diagnostic preparations, all for medical purposes and based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in treatment, diagnosis and prevention of human diseases and conditions, namely, in treatment, diagnosis and prevention of inflammatory diseases, cancer, neurodegenerative diseases, lifestyle diseases, autoimmune diseases, infectious diseases, digestive diseases and endocrine-metabolic diseases, all the aforementioned produced by genome or gene editing operation; cultures of microorganisms for medical or veterinary purposes, produced by genome or gene editing operation; biological tissue cultures for medical or veterinary purposes, produced by genome or gene editing operation

Crop seeds; plant seeds; crop seeds produced by genome or gene editing operation; plant seeds produced by genome or gene editing operation; crop seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; plant seeds in which herbicide tolerance genes are incorporated by genome or gene editing operation; vegetable seeds for planting produced by genome or gene editing operation; seeds for agricultural purposes; vegetable seeds for planting; seeds for planting; genetically modified seeds, namely, seeds for agricultural purposes, flower seeds, seeds for planting, and vegetable seeds, all the aforementioned seeds for planting

Research and development in the field of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, product development advisory services, and scientific research advisory services relating thereto in the fields of protein, antibody, and microorganism scientific study, and the study of cells; structural and functional analysis of the genome with genome editing technology; DNA screening for scientific research purposes with genome editing technology; research and development, product development advisory services, and scientific research advisory services relating thereto in the field of genome editing technology; scientific research in the field of genetics and genetic engineering with genome editing technology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; information services, namely, providing information relating to the development of pharmaceuticals, cosmetics or foodstuffs, all with genome editing technology; scientific and technological services, namely, scientific testing, examination or research relating to medical treatment or medical technology with genome editing technology; information services, namely, providing information for scientific testing, examination or research purposes relating to medical treatment or medical technology with genome editing technology; scientific and technological services, namely, scientific testing or research relating to genome or gene to which genome editing technology is applied; scientific and technical research and technological development of bioinformatic tools in the fields of editing, modulation, modification, engineering, regulation, repair and therapy of gene, genome and cells to develop human pharmaceutical, biological preparations, and diagnostic products and services; research and development for the pharmaceutical industry and biotechnology industry with genome editing technology; research and development of biotechnology for others; research and development of genome editing technology for others; development of pharmaceutical preparations and medicines; biotechnology research; research and development in the field of genomics and biotechnology; technical advisory consulting services in the field of genomics and biotechnology; structural and functional analysis of genomes; scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific and technological services, namely, design of bioinformatic algorithms for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services

Chemicals for use in industry and science; chemical reagents for use in genetic research other than for medical or veterinary purposes; chemical reagents for use in genetic research in the field of genome or gene editing other than for medical or veterinary purposes; chemical substances produced by genome or gene editing operation for analyses in laboratories, other than for medical or veterinary purposes; chemical reagent for separation and production of gene editing substances for non-medical purposes; biotechnologically-formed genes for use in the manufacture of agricultural seeds produced by genome or gene editing operation; cultures of microorganisms produced by genome or gene editing operation, other than for medical or veterinary use; reagents for scientific and research use in the field of genome or gene editing; biotechnologically-formed genes for use in the manufacture of agricultural seeds; cultures of microorganisms, other than for medical or veterinary use

Filing History

POST REGISTRATION ACTION MAILED - SEC. 7
Apr 21, 2026 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 20, 2026 APRE
TEAS SECTION 7 SURRENDER RECEIVED
Jan 28, 2026 ES7S
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 14, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 14, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 14, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 14, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 17, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 5, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 5, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 4, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2024 NWOS
NEW APPLICATION ENTERED
Mar 22, 2024 NWAP